US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
2 deals · US$52.5mdisclosed · Consumer Health · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Jun 2026 | Enhanced Group | – | – | Placement | Pending | 50.0 | Healthcare Services+2 | Cooley (issuer)Cantor Fitzgerald (lead manager)DLA Piper (lead manager) |
| Jan 2026 | Park Ha Biological Technology Co. | – | – | Follow-on offering | Announced | 2.5 | Consumer Health | Ogier (issuer)D. Boral Capital (lead manager)McLaughlin & Stern (lead manager)Jingtian & Gongcheng (lead manager) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built